The vasculature in chagas disease

Advances in Parasitology

Volumn 76, Issue , 2011, Pages 83-99

  Prado, Cibele M ^a   Jelicks, Linda A ^b   Weiss, Louis M ^b   Factor, Stephen M ^b   Tanowitz, Herbert B ^b   Rossi, Marcos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Chagas disease; Chagas heart disease; Cytokines; Endothelin; Inflamamtion; Thromboxane; Trypanosoma cruzi; Vasculature; Vasculitis

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR 1; CYCLIN D1; CYTOKINE; ENDOTHELIN 1; FIBRIN; ICOSANOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INOSITOL TRISPHOSPHATE 3 KINASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; RAF PROTEIN; RUBIDIUM 86; TRANSCRIPTION FACTOR AP 1; VERAPAMIL;

AMASTIGOTE; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ASTROCYTE; BOOK; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; DOG; ENDOTHELIUM; ENZYME ACTIVATION; ENZYME ACTIVITY; EPIMASTIGOTE; FIBROBLAST; FIBROSING ALVEOLITIS; HEART; HEART ANEURYSM; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MUSCLE CELL; MYOCARDITIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOCYST; T LYMPHOCYTE; THROMBOCYTE AGGREGATION; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VASCULARIZATION; VASCULITIS; VASOSPASM;

TRYPANOSOMA CRUZI;

EID: 80052137597     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385895-5.00004-9     Document Type: Chapter

References (87)

1. Acosta A.M., Santos-Buch C.A. Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 1985, 71:1255-1261.
2. Alencar A., DE.Karsten M.R.Q., Cerqueira M.C. Estudo do sistema nervoso autônomo do aparelho digestivo em camundongos albinos cronicamente infectados pelo Schizotrypanum cruzi. Hospital (Rio J.) 1968, 73:165-176.
3. Andrade Z.A., Andrade S.G. Pathogenesis of Chagas' chronic myocarditis; importance of ischemic lesions. Arq. Bras. Med. 1955, 45:279-288.
4. Andrade Z.A., Andrade S.G., Correa R., Sadigursky M., Ferrans V.J. Myocardial changes in acute Trypanosoma cruzi infection. Ultrastructural evidence of immune damage and the role of microangiopathy. Am. J. Pathol. 1994, 144:1403-1411.
5. Ashton A.W., Mukherjee S., Nagajyothi F.N., Huang H., Braunstein V.L., Desruisseaux M.S., et al. Thromboxane A2 is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med. 2007, 204:929-940.
6. Belley A., Chadee K. Eicosanoid production by parasites: from pathogenesis to immunomodulation?. Parasitol. Today 1995, 11:327-334.
7. Bevilacqua M.P., Pober J.S., Majeau G.R., Cotran R.S., Gimbrone M.A. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med. 1984, 160:618-623.
8. Brands M.W., Hildebrandt D.A., Mizelle H.L., Hall J.E. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am. J. Physiol. 1991, 260:R764-R768.
9. Brito T., Vasconcelos E. Necrotizing arteritis in megaesophagus. Histopathology of ninety-one biopsies taken from the cardiac. Rev. Inst. Med. Trop. São Paulo 1959, 1:195-206.
10. Castro R., Kuschnir E., Sgammini H. Evaluacion de la performance cardiaca y perfusion miocardica con radiotrazadores en la cardiopatia chagasica cronica. Rev. Argent. Cardiol. 1988, 17:226-231.
11. Chandra M., Shirani J., Shtutin V., Weiss L.M., Factor S.M., Petkova S.B., et al. Cardioprotective effects of verapamil on myocardial structure and function in a murine model of chronic Trypanosoma cruzi infection (Brazil Strain): an echocardiographic study. Int. J. Parasitol. 2002, 32:207-215.
12. Coelho N.A. Aspecto anatomopatológico do coração na moléstia de Chagas. Rev. Med. Chirurg. S. Paulo 1944, 4:209-211.
13. Combs T.P., Nagajyothi F., Mukherjee S., de Almeida C.J., Jelicks L.A., Schubert W., et al. The adipocyte as an important target cell for Trypanosoma cruzi infection. J. Biol. Chem. 2005, 280:24085-24094.
14. Couceiro A. Lesões do ciático na infecção experimental de cães pelo Schizotrypanum cruzi (nota prévia). Mem. Inst. Oswaldo Cruz (Rio J.) 1943, 39:435-439.
15. De Souza A.P., Tanowitz H.B., Chandra M., Shtutin V., Weiss L.M., Morris S.A., et al. Effects of early and late verapamil administration on the development of cardiomyopathy in experimental chronic Trypanosoma cruzi (Brazil strain) infection. Parasitol. Res. 2004, 92:496-501.
16. Dias E., Laranja F.S., Miranda A., Nobrega G. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 1956, 14:1035-1060.
17. Factor S.M., Minase T., Bhan R., Wolinsky H., Sonnenblick E.H. Hypertensive diabetic cardiomyopathy in the rat: ultrastructural features. Virchows Arch. A Pathol. Pathol. Anat. 1983, 398:305-317.
18. Factor S.M., Cho S., Wittner M., Tanowitz H. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 1985, 34:246-253.
19. Ferrans V.J., Milei J., Tomita Y., Storino R.A. Basement membrane thickening in cardiac myocytes and capillaries in chronic Chagas' disease. Am. J. Cardiol. 1988, 61:1137-1140.
20. Ferreira C.S., Lopes E.R., Chapadeiro E., de Almeida H.O., de Souza W.F., de Silva Neto I.J. Coronariografia post mortem na cardite chagásica crônica: correlação anátomo-radiológica. Arq. Bras. Cardiol. (Sao Paulo) 1980, 34:81-86.
21. Haeggstrom J.Z., Rinaldo-Matthis A., Wheelock C.E., Wetterholm A. Advances in eicosanoid research, novel therapeutic implications. Biochem. Biophys. Res. Commun. 2010, 396:135-139.
22. Hagar J.M., Rahimtoola S.H. Chagas' heart disease in the United States. N. Engl. J. Med. 1991, 325:763-768.
23. Hassan G.S., Mukherjee S., Nagajyothi F., Weiss L.M., Petkova S.B., de Almeida C.J., et al. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect. Immun. 2006, 74:152-159.
24. Higuchi M.L., Fukasawa S., De Brito T., Parzianello L.C., Bellotti G., Ramires J.A. Different microcirculatory and interstitial matrix patterns in idiopathic dilated cardiomyopathy and Chagas' disease: a three dimensional confocal microscopy study. Heart 1999, 82:279-285.
25. Huang H., Calderon T.M., Berman J.W., Braunstein V.L., Weiss L.M., Wittner M., et al. Infection of endothelial cells with Trypanosoma cruzi activates NF-kappaB and induces vascular adhesion molecule expression. Infect. Immun. 1999, 67:5434-5440.
26. Huang H., Chan J., Wittner M., Jelicks L.A., Morris S.A., Factor S.M., et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice. J. Mol. Cell. Cardiol. 1999, 31:75-88.
27. Jörg M.E. Tripanosomiasis cruzi; anarquía angiotopográfica por descapilarización mesenquimorreactiva: cofactor patogénico de la miocardiopatia crónica. Prensa Méd. Argent. 1974, 61:94-106.
28. Jörg M.E. Reactividad de endotelios vasculares frente a antigenos del Trypanosoma cruzi. C. M. Publ. Cient. (Mar del Plata) 1991, 4:134-143.
29. Kedzierski R.M., Yanagisawa M. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 2001, 41:851-876.
30. Koberle F. Strength conditions of the left and right halves of the heart. Cardiologia 1958, 33:384-394.
31. Koberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 1968, 6:63-116.
32. Kubata B.K., Eguchi N., Urade Y., Yamashita K., Mitamura T., Tai K., et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J. Exp. Med. 1998, 188:1197-1202.
33. Kubata B.K., Duszenko M., Kabututu Z., Rawer M., Szallies A., Fujimori K., et al. Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. J. Exp. Med. 2000, 192:1327-1338.
34. Kuschnir E., Kustich F., Epelman M., Santamarina N., Podio R.B. Valoración del flujo miocárdico con Rb 86, en pacientes con cardiopatia chagasica, con insuficiencia coronaria y en controles normales. Parte 1: estudios basales. Arq. Bras. Cardiol. (Sao Paulo) 1974, 27:187-196.
35. Kuschnir E., Kustich F., Epelman M., Santamarina N., Podio R.B. Valoración del flujo miocárdico con Rb 86, en pacientes con cardiopatia chagasica, con insuficiencia coronaria y en controles normales. Parte 2: respuesta al ejercicio y la cardiotonificación aguda. Arq. Bras. Cardiol. (Sao Paulo) 1974, 27:721-732.
36. Laucella S., De Titto E.H., Segura E.L., Orn A., Rottenberg M.E. Soluble cell adhesion molecules in human Chagas' disease: association with disease severity and stage of infection. Am. J. Trop. Med. Hyg. 1996, 55:629-634.
37. Lee Y.M., Chen W.F., Chou D.S., Jayakumar T., Hou S.Y., Lee J.J., et al. Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation. J. Biomed. Sci. 2010, 17:45.
38. Libby P., Alroy J., Pereira M.E. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. J. Clin. Invest. 1986, 77:127-135.
39. Liu L.X., Weller P.F. Arachidonic acid metabolism in filarial parasites. Exp. Parasitol. 1990, 71:496-501.
40. Liu M., Wang F., Wang Y., Jin R. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation. Cardiovasc. Drugs Ther. 2009, 23:369-376.
41. Lucena D.T., Carvalho J.A.M., Abath E.C., Amorim N. Terapêutica experimental da doença de Chagas. I. Ação de uma 8-aminoquinoleina em ratos albinos. Hospital (Rio J.) 1962, 62:1278-1296.
42. Macclure E., Poche R. Microscopia eletrônica da miocardite chagásica experimental em camundongos albinos. Int. Cong. Trop. Med. Malar. 1963, 2:249-250.
43. Machado F.S., Desruisseaux M.S., Nagajyothi F., Kennan R.P., Hetherington H.P., Wittner M., et al. Endothelin in a murine model of cerebral malaria. Exp. Biol. Med. 2006, 231:1176-1181.
44. Mantovani A., Sica A., Colotta F., Dejana E. The role of cytokines as communication signals between leukocytes and endothelial cells. Prog. Clin. Biol. Res. 1990, 349:343-353.
45. Marin-Neto J.A., Marzullo P., Marcassa C., Gallo Junior L., Maciel B.C., Bellina C.R., et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am. J. Cardiol. 1992, 69:780-784.
46. Mazza S., Benitez C. Comprobación de la natureza esquizotripanósica y frecuencia de la dacrioretinitis en la enfermedad de Chagas. M.E.P.R.A. 1937, 31:3-31.
47. Melo L., Caldas I.S., Azevedo M.A., Goncalves K.R., da Silva do Nascimento A.F., Figueiredo V.P., et al. Low doses of simvastatin therapy ameliorate cardiac inflammatory remodeling in Trypanosoma cruzi-infected dogs. Am. J. Trop. Med. Hyg. 2011, 84:325-331.
48. Morris S.A., Tanowitz H., Hatcher V., Bilezikian J.P., Wittner M. Alterations in intracellular calcium following infection of human endothelial cells with Trypanosoma cruzi. Mol. Biochem. Parasitol. 1988, 29:213-221.
49. Morris S.A., Weiss L.M., Factor S., Bilezikian J.P., Tanowitz H., Wittner M. Verapamil ameliorates clinical, pathologic and biochemical manifestations of experimental chagasic cardiomyopathy in mice. J. Am. Coll. Cardiol. 1989, 14:782-789.
50. Morris S.A., Tanowitz H., Makman M., Hatcher V.B., Bilezikian J.P., Wittner M. Trypanosoma cruzi: alteration of cAMP metabolism following infection of human endothelial cells. Exp. Parasitol. 1992, 74:69-76.
51. Mukherjee S., Huang H., Petkova S.B., Albanese C., Pestell R.G., Braunstein V.L., et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect. Immun. 2004, 72:5274-5282.
52. Mukherjee S., Machado F.S., Huang H., Oz H.S., Jelicks L.A., Prado C.M., et al. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One 2011, 6:e16959.
53. Nachman R.L., Hajjar K.A., Silverstein R.L., Dinarello C.A. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J. Exp. Med. 1986, 163:1595-1600.
54. Noverr M.C., Erb-Downward J.R., Huffnagle G.B. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin. Microbiol. Rev. 2003, 16:517-533.
55. Okumura M., Silva A.C., Correa Neto A. Contribuição para o estudo da patogenia das lesões vasculares na doença de Chagas experimental em camundongos brancos. Rev. Paulista Med. (Sao Paulo) 1962, 61:265-266.
56. Oliveira J.S. A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy. Am. Heart J. 1985, 110:1092-1098.
57. Petkova S.B., Tanowitz H.B., Magazine H.I., Factor S.M., Chan J., Pestell R.G., et al. Myocardial expression of endothelin-1 in murine Trypanosoma cruzi infection. Cardiovasc. Pathol. 2000, 9:257-265.
58. Petkova S.B., Huang H., Factor S.M., Pestell R.G., Bouzahzah B., Jelicks L.A., et al. The role of endothelin in the pathogenesis of Chagas' disease. Int. J. Parasitol. 2001, 31:499-511.
59. Ramos J.J., Tibiriça P.Q.T. Miocardite crônica na moléstia de Chagas. Rev. Bras. Med. 1945, 2:1-9.
60. Reis D.D., Jones E.M., Tostes S., Lopes E.R., Chapadeiro E., Gazzinelli G., et al. Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am. J. Trop. Med. Hyg. 1993, 49:192-200.
61. Ribeiro-dos-Santos R., Rossi M.A. Imunopatologia 1985, Fundação Carlos Chagas, Belo Horizonte, Brazil.
62. Rossi M.A. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am. Heart J. 1990, 120:233-236.
63. Rossi M.A. Aortic endothelial cell changes in the acute septicemic phase of experimental Trypanosoma cruzi infection in rats: scanning and transmission electron microscopic study. Am. J. Trop. Med. Hyg. 1997, 57:321-327.
64. Rossi M.A., Bestetti R.B. The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology 1995, 86:1-7.
65. Rossi M.A., Goncalves S., Ribeiro-dos-Santos R. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am. J. Pathol. 1984, 114:209-216.
66. Rossi M.A., Tanowitz H.B., Malvestio L.M., Celes M.R., Campos E.C., Blefari V., et al. Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms. PLoS Negl. Trop. Dis. 2010, 4:e674.
67. Salomone O.A., Caeiro T.F., Madoery R.J., Amuchastegui M., Omelinauk M., Juri D., et al. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 2001, 87:1217-1220. A1217.
68. Sarabanda A.V., Sosa E., Simoes M.V., Figueiredo G.L., Pintya A.O., Marin-Neto J.A. Ventricular tachycardia in Chagas' disease: a comparison of clinical, angiographic, electrophysiologic and myocardial perfusion disturbances between patients presenting with either sustained or nonsustained forms. Int. J. Cardiol. 2005, 102:9-19.
69. Simoes M.V., Pintya A.O., Bromberg-Marin G., Sarabanda A.V., Antloga C.M., Pazin-Filho A., et al. Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy. Am. J. Cardiol. 2000, 86:975-981.
70. Sonnenblick E.H., Fein F., Capasso J.M., Factor S.M. Microvascular spasm as a cause of cardiomyopathies and the calcium-blocking agent verapamil as potential primary therapy. Am. J. Cardiol. 1985, 55:179B-184B.
71. Talvani A., Santana G., Barcelos L.S., Ishii S., Shimizu T., Romanha A.J., et al. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. Microbes Infect. 2003, 5:789-796.
72. Tanowitz H.B., Burns E.R., Sinha A.K., Kahn N.N., Morris S.A., Factor S.M., et al. Enhanced platelet adherence and aggregation in Chagas' disease: a potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 1990, 43:274-281.
73. Tanowitz H.B., Gumprecht J.P., Spurr D., Calderon T.M., Ventura M.C., Raventos-Suarez C., et al. Cytokine gene expression of endothelial cells infected with Trypanosoma cruzi. J. Infect. Dis. 1992, 166:598-603.
74. Tanowitz H.B., Morris S.A., Factor S.M., Weiss L.M., Wittner M. Parasitic diseases of the heart I: acute and chronic Chagas' disease. Cardiovasc. Pathol. 1992, 1:7-15.
75. Tanowitz H.B., Kaul D.K., Chen B., Morris S.A., Factor S.M., Weiss L.M., et al. Compromised microcirculation in acute murine Trypanosoma cruzi infection. J. Parasitol. 1996, 82:124-130.
76. Tanowitz H.B., Huang H., Jelicks L.A., Chandra M., Loredo M.L., Weiss L.M., et al. Role of endothelin 1 in the pathogenesis of chronic chagasic heart disease. Infect. Immun. 2005, 73:2496-2503.
77. Tanowitz H.B., Machado F.S., Jelicks L.A., Shirani J., de Carvalho A.C., Spray D.C., et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog. Cardiovasc. Dis. 2009, 51:524-539.
78. Tonelli R.R., Giordano R.J., Barbu E.M., Torrecilhas A.C., Kobayashi G.S., Langley R.R., et al. Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo. PLoS Negl. Trop. Dis. 2010, 4:e864.
79. Torres C.M. Estudo do miocárdio na moléstia de Chagas (forma aguda). Mem. Inst. Oswaldo Cruz (Rio J.) 1917, 9:114-139.
80. Torres C.M. Sobre a anatomia patológica da doença de Chagas. Hospital (Rio J.) 1941, 36:391-409.
81. Torres C.M. Miocitólise e fibrose do miocárdio na doença de Chagas. Mem. Inst. Oswaldo Cruz (Rio J.) 1960, 58:161-182.
82. Torres F.W., Acquatella H., Condado J.A., Dinsmore R., Palacios I.F. Coronary vascular reactivity is abnormal in patients with Chagas' heart disease. Am. Heart J. 1995, 129:995-1001.
83. Van Voorhis W.C. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J. Immunol. 1992, 148:239-248.
84. Vianna G. Contribuição para o estudo da anatomia patológica da moléstia de Carlos Chagas. Mem. Inst. Oswaldo Cruz (Rio J.) 1911, 3:199-226.
85. Vianna L.G., Campos G.P., de Magalhaes A.V. Myocardial infarct without coronary obstruction associated with chronic Chagas cardiopathy. Arq. Bras. Cardiol. 1979, 33:41-47.
86. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
87. Zhang L., Tarleton R.L. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease. J. Infect. Dis. 1999, 180:480-486.